Alkem subsidiary Enzene launches adalimumab biosimilar in India

Enzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news